Open AccessNet Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
Author(s) -
Leif Friberg,
Mårten Rosenqvist,
Gregory Y.H. Lip
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.055079
Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , anticoagulant , anticoagulant therapy , cardiology , mechanical engineering , engineering
Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom